David Seaburg
Chief Executive Officer at STELLA DIAGNOSTICS INC.
Net worth: 7 775 $ as of 2024-03-30
Profile
David Seaburg is currently the Chief Executive Officer & Director at Stella Diagnostics, Inc. and the Director at Stella Diagnostics LLC.
Previously, he worked as the Managing Director & Head-Sales Trading at Cowen & Co. LLC from 1998 to 2020.
He also served as the Director at RegenETP, Inc. from 2021 to 2023.
Mr. Seaburg obtained his undergraduate degree from Northeastern University in 1993.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
REGENETP INC.
0.97% | 2023-03-19 | 71,272 ( 0.97% ) | 7 127 $ | 2024-03-30 |
STELLA DIAGNOSTICS INC.
0.10% | 2022-06-29 | 9,000 ( 0.10% ) | 648 $ | 2024-03-30 |
David Seaburg active positions
| Companies | Position | Start |
|---|---|---|
| STELLA DIAGNOSTICS INC. | Chief Executive Officer | 2022-04-21 |
Stella Diagnostics LLC
 Stella Diagnostics LLC Medical SpecialtiesHealth Technology Stella Diagnostics LLC engages in the provision of molecular diagnostic services. Its StellaDX’s mass spec proteomic assays offers physicians insight into the molecular properties of patients’ tissue to determine if the disease is stable, progressing or turning cancerous. The company is headquartered in New York, NY. | Director/Board Member | 2021-02-24 |
Former positions of David Seaburg
| Companies | Position | End |
|---|---|---|
| REGENETP, INC. | Chief Executive Officer | 2021-08-31 |
Cowen & Co. LLC
 Cowen & Co. LLC Investment Banks/BrokersFinance Cowen & Co. LLC is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 2004 and is a subsidiary of Cowen Holdings, Inc., ultimately owned by The Toronto-Dominion Bank (TSE: TD) in Canada. Cowen & Co. offers industry-focused investment banking for growth-oriented companies, domain knowledge-driven research and a sales and trading platform for institutional investors. Their institutional sales and trading business serves both equity and fixed-income clients. Sales and trading execution platform is structured around the following key verticals: (1) healthcare (2) technology, telecommunications and media (TMT) (3) REITs and financials (4) aerospace and defense (5) consumer and (6) alternative energy. | Sales & Marketing | 2020-04-30 |
Training of David Seaburg
| Northeastern University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| REGENETP, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Cowen & Co. LLC
Cowen & Co. LLC Investment Banks/BrokersFinance Cowen & Co. LLC is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 2004 and is a subsidiary of Cowen Holdings, Inc., ultimately owned by The Toronto-Dominion Bank (TSE: TD) in Canada. Cowen & Co. offers industry-focused investment banking for growth-oriented companies, domain knowledge-driven research and a sales and trading platform for institutional investors. Their institutional sales and trading business serves both equity and fixed-income clients. Sales and trading execution platform is structured around the following key verticals: (1) healthcare (2) technology, telecommunications and media (TMT) (3) REITs and financials (4) aerospace and defense (5) consumer and (6) alternative energy. | Finance |
Stella Diagnostics LLC
Stella Diagnostics LLC Medical SpecialtiesHealth Technology Stella Diagnostics LLC engages in the provision of molecular diagnostic services. Its StellaDX’s mass spec proteomic assays offers physicians insight into the molecular properties of patients’ tissue to determine if the disease is stable, progressing or turning cancerous. The company is headquartered in New York, NY. | Health Technology |
| Stella Diagnostics, Inc. |
- Stock Market
- Insiders
- David Seaburg
